Treating inflammation after lens surgery
- PMID: 26703275
- DOI: 10.1016/j.jcrs.2015.10.056
Treating inflammation after lens surgery
Comment in
-
Corticosteroids substituted by nonsteroidal antiinflammatory drugs: Is it justified by evidence-based medicine?J Cataract Refract Surg. 2016 Mar;42(3):510-1. doi: 10.1016/j.jcrs.2016.02.028. J Cataract Refract Surg. 2016. PMID: 27063546 No abstract available.
-
Reply.J Cataract Refract Surg. 2016 Mar;42(3):511. doi: 10.1016/j.jcrs.2016.03.011. J Cataract Refract Surg. 2016. PMID: 27063547 No abstract available.
Similar articles
-
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.J Cataract Refract Surg. 2015 Oct;41(10):2043-8. doi: 10.1016/j.jcrs.2015.10.061. J Cataract Refract Surg. 2015. PMID: 26703278 Clinical Trial.
-
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.Adv Ther. 2011 Dec;28(12):1089-95. doi: 10.1007/s12325-011-0080-7. Epub 2011 Nov 18. Adv Ther. 2011. PMID: 22105509 Clinical Trial.
-
Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.Dev Ophthalmol. 2016;55:212-20. doi: 10.1159/000431197. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26502088 Review.
-
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.Br J Ophthalmol. 2015 May;99(5):654-8. doi: 10.1136/bjophthalmol-2014-305803. Epub 2014 Nov 10. Br J Ophthalmol. 2015. PMID: 25385061 Clinical Trial.
-
Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.Int Ophthalmol Clin. 2006 Fall;46(4):21-40. doi: 10.1097/01.iio.0000212134.83513.11. Int Ophthalmol Clin. 2006. PMID: 17060789 Review. No abstract available.
Cited by
-
Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery.J Ophthalmol. 2022 Jul 19;2022:4857696. doi: 10.1155/2022/4857696. eCollection 2022. J Ophthalmol. 2022. PMID: 35903174 Free PMC article.
-
Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins.J Clin Med. 2021 Aug 8;10(16):3494. doi: 10.3390/jcm10163494. J Clin Med. 2021. PMID: 34441790 Free PMC article.
-
Cataract surgeon viewpoints on the need for novel preventative anti-inflammatory and anti-posterior capsular opacification therapies.Curr Med Res Opin. 2019 Nov;35(11):1971-1981. doi: 10.1080/03007995.2019.1647012. Epub 2019 Aug 28. Curr Med Res Opin. 2019. PMID: 31328581 Free PMC article.
-
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial.Front Pharmacol. 2020 Apr 16;11:440. doi: 10.3389/fphar.2020.00440. eCollection 2020. Front Pharmacol. 2020. PMID: 32372954 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical